ANI PHARMACEUTICALS, INC Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31)
ANI PHARMACEUTICALS, INC (ANIP) reported Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) of -$8.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Notes › Equity
us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 · last filed 2020-08-06
- ANI PHARMACEUTICALS, INC cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2020-06-30 was $0.00.
- ANI PHARMACEUTICALS, INC cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2020-03-31 was -$8.00K, a 500.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2019-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2019-06-30 was $0.00.
| Period end | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 1 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 3 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 6 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 9 month |
|---|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$8.00K 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | -$8.00K 10-Q · filed 2020-05-07 | ||||
| 2020-01-31 | $8.00K 10-Q · filed 2020-05-07 | ||||
| 2020-01-01 | -$8.00K 10-Q · filed 2020-08-06 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-08-06 | $2.00K 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $2.00K 10-Q · filed 2020-05-07 | ||||
| 2019-01-31 | $2.00K 10-Q · filed 2019-11-06 | ||||
| 2019-01-01 | $2.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |